December 8, 2025Blood

Clinical outcomes associated with serological subsets of heparin-induced thrombocytopenia

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective cohort study shows heparin-independent platelet activation increases thrombosis risk in HIT, indicating need for improved reporting.

To assess how different serological subsets of heparin-induced thrombocytopenia affect clinical outcomes.
Retrospective cohort study at McMaster University focusing on HIT patients
Included patients with positive anti-PF4/heparin enzyme immunoassay and SRA results
Analyzed baseline demographics, thrombosis history, and lab values
Conducted univariate analyses and logistic regression to assess thrombosis risk
52% of patients demonstrated heparin-independent platelet activation
Higher 4T scores and optical density in heparin-independent patients
Associated with worse outcomes: lower nadir platelet count and increased thrombosis risk
Heparin-independent serology linked to higher risk of myocardial infarction and cerebral sinus venous thrombosis

Kwok et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective cohort study shows heparin-independent platelet activation increases thrombosis risk in HIT, indicating need for improved reporting.